OUTCOMES OF ULTRASOUND-GUIDED INJECTIONS OF BENNETT LESIONS OF THE SHOULDER

This study describes the technique and short-term follow-up of ultrasound-guided injections for treating symptomatic Bennett lesions in baseball players. From August 2014 to August 2021, 13 injections were performed on 10 male players (mean age 25 years), including major and minor league pitchers and a high school pitcher. The procedure involved a posterior approach glenohumeral injection with a slightly medial transducer position. Anesthetic and steroid were injected onto the Bennett lesion surface, avoiding the glenohumeral joint. MRIs confirmed Bennett lesions in all patients, with ultrasound corroborating in most cases. Immediate symptom relief was reported in 67% of injections, with no complications. Fastball velocity data showed minimal post-procedure changes, with mixed results on the long-term effectiveness. The study concludes that while the procedure is safe and can provide temporary relief, its clinical utility varies.

4

Quiz 115

1 / 5

What potential application does this technology have in treating brain diseases?

 

2 / 5

What is the primary advantage of using ultrasound and microbubbles in brain therapy?

 

3 / 5

How does ultrasound work in conjunction with microbubbles to facilitate drug delivery?

 

4 / 5

What role do microbubbles play in delivering immunotherapy to the brain?

 

5 / 5

What challenges does the blood-brain barrier (BBB) present in treating brain diseases?

 

OUTCOMES OF ULTRASOUND-GUIDED INJECTIONS OF BENNETT LESIONS OF THE SHOULDER

by Echo Writer time to read: 1 min
0

Contact Support

If you're interested in posting an article and need assistance, please don't hesitate to contact our support team. We're here to help you through the process, answer any questions you may have, and ensure that your article is published smoothly and effectively.

support@ehealthcommunity.org